tiprankstipranks
Trending News
More News >
Seres Therapeutics Inc. (MCRB)
NASDAQ:MCRB
US Market

Seres Therapeutics (MCRB) Ratios

Compare
1,086 Followers

Seres Therapeutics Ratios

MCRB's free cash flow for Q3 2025 was $-37.04. For the 2025 fiscal year, MCRB's free cash flow was decreased by $ and operating cash flow was $23.37. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
2.30 0.94 1.78 2.28 3.69
Quick Ratio
2.30 0.94 1.48 2.28 3.69
Cash Ratio
2.12 0.75 1.30 1.90 2.19
Solvency Ratio
0.10 0.04 -0.27 -0.72 -0.23
Operating Cash Flow Ratio
-1.03 -3.61 -1.19 -2.67 0.08
Short-Term Operating Cash Flow Coverage
-2.32 0.00 0.00 -501.79 1.01
Net Current Asset Value
$ -48.25M$ -87.35M$ -228.05M$ -143.24M$ 80.28M
Leverage Ratios
Debt-to-Assets Ratio
0.59 0.66 0.60 0.47 0.14
Debt-to-Equity Ratio
1.95 6.65 -4.77 15.08 0.37
Debt-to-Capital Ratio
0.66 0.87 1.27 0.94 0.27
Long-Term Debt-to-Capital Ratio
0.00 0.00 1.79 0.82 0.16
Financial Leverage Ratio
3.28 10.14 -7.99 32.35 2.70
Debt Service Coverage Ratio
0.98 0.00 -7.16 -37.24 -5.53
Interest Coverage Ratio
0.00 0.00 -8.20 -40.95 -22.16
Debt to Market Cap
0.07 0.00 0.57 0.08 0.04
Interest Debt Per Share
9.73 11.79 35.49 1.56 0.57
Net Debt to EBITDA
3.89 -0.51 -0.91 <0.01 2.31
Profitability Margins
Gross Profit Margin
-5010.54%0.00%99.44%85.91%98.80%
EBIT Margin
1536.75%0.00%-79.59%-3425.04%-43.24%
EBITDA Margin
2755.84%0.00%-74.65%-3332.04%-39.14%
Operating Profit Margin
-29466.95%0.00%-85.48%-3458.05%-44.50%
Pretax Profit Margin
1536.75%0.00%-90.02%-3509.50%-45.25%
Net Profit Margin
1536.75%0.00%-90.02%-3560.94%-42.43%
Continuous Operations Profit Margin
1536.75%0.00%-90.02%-3509.50%-45.25%
Net Income Per EBT
100.00%-0.11%100.00%101.47%93.78%
EBT Per EBIT
-5.22%103.67%105.32%101.49%101.68%
Return on Assets (ROA)
3.76%0.10%-31.71%-72.77%-17.33%
Return on Equity (ROE)
15.31%0.99%253.53%-2353.93%-46.76%
Return on Capital Employed (ROCE)
-85.45%-123.05%-41.54%-93.66%-23.66%
Return on Invested Capital (ROIC)
-78.98%-113.10%-40.50%-93.59%-21.16%
Return on Tangible Assets
3.76%0.10%-31.71%-72.77%-17.33%
Earnings Yield
4.03%0.11%-63.46%-41.94%-8.05%
Efficiency Ratios
Receivables Turnover
0.45 0.00 14.56 0.00 0.00
Payables Turnover
10.70 0.87 0.19 0.06 0.13
Inventory Turnover
0.00 0.00 0.02 0.00 0.00
Fixed Asset Turnover
<0.01 0.00 0.96 0.05 4.01
Asset Turnover
<0.01 0.00 0.35 0.02 0.41
Working Capital Turnover Ratio
0.01 0.00 1.36 0.04 0.65
Cash Conversion Cycle
773.87 -421.53 13.51K -6.34K -2.89K
Days of Sales Outstanding
807.99 0.00 25.06 0.00 0.00
Days of Inventory Outstanding
0.00 0.00 15.37K 0.00 0.00
Days of Payables Outstanding
34.12 421.53 1.89K 6.34K 2.89K
Operating Cycle
807.99 0.00 15.40K 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
-2.63 -19.13 -18.34 -2.12 0.07
Free Cash Flow Per Share
-2.67 -19.17 -19.58 -2.21 -0.03
CapEx Per Share
0.04 0.05 1.25 0.09 0.10
Free Cash Flow to Operating Cash Flow
1.01 1.00 1.07 1.04 -0.43
Dividend Paid and CapEx Coverage Ratio
-73.66 -391.08 -14.72 -23.30 0.70
Capital Expenditure Coverage Ratio
-73.66 -391.08 -14.72 -23.30 0.70
Operating Cash Flow Coverage Ratio
-0.27 -1.62 -0.55 -1.41 0.14
Operating Cash Flow to Sales Ratio
-65.68 0.00 -0.93 -32.10 0.05
Free Cash Flow Yield
-16.91%-115.37%-69.94%-39.43%-0.38%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
24.81 949.54 -1.58 -2.38 -12.42
Price-to-Sales (P/S) Ratio
393.82 0.00 1.42 84.91 5.27
Price-to-Book (P/B) Ratio
3.06 9.37 -4.00 56.13 5.81
Price-to-Free Cash Flow (P/FCF) Ratio
-5.92 -0.87 -1.43 -2.54 -265.42
Price-to-Operating Cash Flow Ratio
-5.80 -0.87 -1.53 -2.65 114.22
Price-to-Earnings Growth (PEG) Ratio
0.23 154.14 0.03 >-0.01 0.33
Price-to-Fair Value
3.06 9.37 -4.00 56.13 5.81
Enterprise Value Multiple
18.18 -1.58 -2.81 -2.55 -11.16
Enterprise Value
175.85M 189.99M 265.18M 604.79M 633.09M
EV to EBITDA
18.18 -1.58 -2.81 -2.55 -11.16
EV to Sales
500.99 0.00 2.10 84.85 4.37
EV to Free Cash Flow
-7.53 -1.28 -2.12 -2.53 -219.98
EV to Operating Cash Flow
-7.63 -1.28 -2.26 -2.64 94.66
Tangible Book Value Per Share
4.99 1.77 -7.01 0.10 1.43
Shareholders’ Equity Per Share
4.99 1.77 -7.01 0.10 1.43
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 0.00 -0.01 0.06
Revenue Per Share
0.04 0.00 19.74 0.07 1.58
Net Income Per Share
0.62 0.02 -17.77 -2.35 -0.67
Tax Burden
1.00 >-0.01 1.00 1.01 0.94
Interest Burden
1.00 1.00 1.13 1.02 1.05
Research & Development to Revenue
107.13 0.00 1.15 24.26 0.98
SG&A to Revenue
125.58 0.00 0.69 11.18 0.48
Stock-Based Compensation to Revenue
25.42 0.00 0.27 3.57 0.14
Income Quality
-4.27 -1.09K 1.03 0.91 -0.10
Currency in USD